We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Massachusetts Devicemaker Hit for Discrepancy Investigation Reports
Massachusetts Devicemaker Hit for Discrepancy Investigation Reports
The FDA cited Acorda Therapeutics’ Chelsea, Massachusetts manufacturing facility for its handling of discrepancy investigations observed during a June 4-18, 2018 inspection.